(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.07%) $82.75
(0.36%) $1.659
(-0.32%) $2 330.90
(-0.30%) $27.27
(-0.22%) $913.80
(-0.02%) $0.934
(0.02%) $10.98
(-0.01%) $0.802
(0.00%) $92.32
Live Chart Being Loaded With Signals
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States...
Stats | |
---|---|
Today's Volume | 11.25M |
Average Volume | 3.10M |
Market Cap | 0.00 |
EPS | $-0.980 ( 2022-02-28 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.56 |
ATR14 | $0.603 (2.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-03-07 | Breitmeyer James B | Sell | 1 250 | Common Stock |
2022-03-07 | Breitmeyer James B | Sell | 9 375 | Stock Option (Right to Buy) |
2022-03-07 | Breitmeyer James B | Sell | 6 250 | Stock Option (Right to Buy) |
2022-03-07 | Breitmeyer James B | Sell | 9 000 | Stock Option (Right to Buy) |
2022-03-07 | Breitmeyer James B | Sell | 10 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 100 transactions |
Buy: 446 833 | Sell: 2 096 567 |
Volume Correlation
Zogenix Inc Correlation
10 Most Positive Correlations | |
---|---|
BRACU | 0.97 |
ATRS | 0.969 |
ATCX | 0.967 |
XLRN | 0.957 |
CTSO | 0.955 |
EYEN | 0.952 |
ARAY | 0.947 |
NVCN | 0.946 |
ALGN | 0.945 |
FOCS | 0.945 |
10 Most Negative Correlations | |
---|---|
NAKD | -0.948 |
TRIT | -0.935 |
AHPI | -0.931 |
AMRB | -0.922 |
GRPH | -0.922 |
GRIN | -0.909 |
PROC | -0.907 |
CHKEL | -0.905 |
TUEM | -0.904 |
LAWS | -0.902 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zogenix Inc Correlation - Currency/Commodity
Zogenix Inc Financials
Annual | 2021 |
Revenue: | $81.69M |
Gross Profit: | $76.86M (94.08 %) |
EPS: | $-4.24 |
Q4 | 2021 |
Revenue: | $26.61M |
Gross Profit: | $24.97M (93.83 %) |
EPS: | $-0.980 |
Q3 | 2021 |
Revenue: | $22.61M |
Gross Profit: | $21.32M (94.28 %) |
EPS: | $-1.040 |
Q2 | 2021 |
Revenue: | $18.79M |
Gross Profit: | $17.57M (93.50 %) |
EPS: | $-1.050 |
Financial Reports:
No articles found.
Zogenix Inc
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators